This week’s Medical Minute, discusses the newest gene editing technology, called “prime editing”, that scientists say may be as effective as CRISPR at editing DNA, with less collateral damage.
An international team has put human cells into monkey embryos in hopes of finding new ways to produce organs for transplantation. But some ethicists still worry about how such research could go wrong.
COVID-19 vaccines are highly effective but don't always provide perfect protection. Some vaccinated people later exposed to the virus still get sick. Why and how often that happens is under study.
In this week’s Medical Minute, new developments in “cell reprogramming” that could help patients recover from spinal cord injuries which lead to permanent paralysis in the past.
Researchers are reporting some progress in their search for drugs that tamp down the overwhelming immune reaction that can kill a patient with COVID-19.
A medical team in New York City says it has performed the first complete surgical transplant of a trachea. These kinds of transplants are one of the last big transplant challenges.
This week’s Medical Minute, discusses cystic fibrosis research into how nutrition, body composition and exercise play in patients’ health across an increasing lifespan. One major goal is to better pinpoint who will develop CF-related diabetes.
Scientists found remains of parrots in the Atacama desert, far from the birds' home in the Amazon. The discovery allowed scientists to reconstruct ancient trading routes used to transport the birds.
From fish in jars to rare seeds and microbes, hundreds of millions of biological specimens are stored around the U.S., and caretakers are trying to make them accessible for future research.
This week’s Medical Minute, discusses a manmade molecule called “givinostat” that coaxes stem cells, which have the potential to become any cell type, to become “muscle progenitor cells”, which are useful for recovery from injuries, and the loss of muscle mass that comes with aging.
Getting the COVID-19 vaccine into most Americans' arms will involve much more than a good supply and logistics. Values such as equity, deep listening, and informed choice are crucial, too.
A rare blood clotting condition has occurred in some people after receiving the AstraZeneca COVID-19 vaccine. If the new research is correct, it could mean that blood clots could be easily treated.
This week’s Medical Minute, discusses a compound called “EnnA”, which is isolated from a fungus growing on the roots of a flowering plant in Morocco. It is showing signs of being a powerful new weapon in the battle against aggressive, triple negative breast cancer.
